The ACC, SCAI and STS have shared early support for expanding Medicare coverage to include TAVR in patients with native AR.

CHICAGO — A transcatheter aortic valve implantation (TAVI) device developed specifically for the treatment for aortic regurgitation has met all the prespecified safety and efficacy goals, so far, in ...

The U.S. Centers for Medicare and Medicaid Services (CMS) is considering another substantial update to its transcatheter ...

Please provide your email address to receive an email when new articles are posted on . A transcatheter aortic valve replacement system designed to treat aortic regurgitation exceeded its safety and ...

Barcelona, Spain - New data published this week question the role of vasodilators in patients with asymptomatic, chronic, severe aortic regurgitation [1]. In the randomized study, published in the ...

Aortic insufficiency is a potentially severe condition that affects the heart’s ability to pump blood. There are many possible causes for this condition. Aortic insufficiency is a form of heart valve ...

According to a new study the Ross procedure can be safely performed in adults with previous cardiac surgery. However, prior ...

WASHINGTON, DC—There’s fresh evidence that off-label use of TAVR devices for pure native aortic valve regurgitation (NAVR) is associated with “not optimal” outcomes, although newer-generation devices, ...

Aortic regurgitation (AR) may occur due to damage to the aortic valve leaflets or as a result of dilation of the aortic annulus. As the disease progresses, symptoms of heart failure eventually occur.

NEW YORK, NY—For patients with pure native aortic regurgitation (AR) who are undergoing TAVI, use of devices tailored to treat the AR seems to provide superior outcomes compared with off-label use of ...